Latest Breaking News On - Pierre gravier - Page 2 : comparemela.com

PTC Therapeutics (NASDAQ:PTCT) Price Target Cut to $45 00 by Analysts at Cantor Fitzgerald

PTC Therapeutics (NASDAQ:PTCT – Get Free Report) had its target price dropped by research analysts at Cantor Fitzgerald from $51.00 to $45.00 in a research note issued on Friday, Benzinga reports. The brokerage currently has an “overweight” rating on the biopharmaceutical company’s stock. Cantor Fitzgerald’s target price would indicate a potential upside of 69.43% from […]

Pierre gravierMatthewb kleinChina universal asset management coRoyal bankTherapeutics incCantor fitzgeraldHeadlands technologiesNisa investment advisorsLazard asset managementWells fargo companyAllspring global investments holdingsGet free reportWells fargoTrading downUniversal asset managementInvestment advisors

PTC Therapeutics, Inc (NASDAQ:PTCT) Receives Consensus Recommendation of Reduce from Analysts

PTC Therapeutics, Inc (NASDAQ:PTCT) Receives Consensus Recommendation of Reduce from Analysts
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesMichael schmertzlerPierre gravierPtc therapeutics incWells fargo companySecurities exchange commissionAmerican century companies incVise technologies incDimensional fund advisorsCantor fitzgeraldMorgan stanleyEllsworth advisorsTherapeutics incGet free reportExchange commissionDirector michael schmertzler

Panagora Asset Management Inc Has $6 82 Million Stock Holdings in PTC Therapeutics, Inc (NASDAQ:PTCT)

Panagora Asset Management Inc Has $6 82 Million Stock Holdings in PTC Therapeutics, Inc (NASDAQ:PTCT)
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United statesPierre gravierPanagora asset management incDimensional fund advisorsCantor fitzgeraldMorgan stanleyExchange commissionVise technologies incAmerican century companies incEllsworth advisorsTherapeutics incSecurities exchange commissionPanagora asset managementFree reportAsset managementFund advisors

FY2028 Earnings Estimate for PTC Therapeutics, Inc (NASDAQ:PTCT) Issued By Leerink Partnrs

FY2028 Earnings Estimate for PTC Therapeutics, Inc (NASDAQ:PTCT) Issued By Leerink Partnrs
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

New zealand generalNew zealandLeerink partnrsMark elliott bouldingPierre gravierNorges bankArmistice capitalWells fargo companyWellington management groupTherapeutics incSecurities exchange commissionPtc therapeutics incMorgan stanleyCantor fitzgeraldFree reportGet free report

PTC Therapeutics (NASDAQ:PTCT) Shares Gap Up on Insider Buying Activity

PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) gapped up before the market opened on Friday after an insider bought additional shares in the company. The stock had previously closed at $27.60, but opened at $28.48. PTC Therapeutics shares last traded at $28.99, with a volume of 288,521 shares traded. Specifically, CFO Pierre Gravier purchased […]

Pierre gravierTherapeutics incAllspring global investments holdingsMorgan stanleySecurities exchange commissionNisa investment advisorsTherapeutics company profilePtc therapeutics incHeadlands technologiesChina universal asset management coLazard asset managementWells fargo companyRoyal bankGet free reportExchange commissionWells fargo